{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T14:54:44Z","timestamp":1774709684263,"version":"3.50.1"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijcard.2024.131853","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T04:59:00Z","timestamp":1708145940000},"page":"131853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Diagnostic and management strategies in cardiac sarcoidosis"],"prefix":"10.1016","volume":"403","author":[{"given":"Jasmine K.","family":"Malhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chukwuka","family":"Ibecheozor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Chrispin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha A.","family":"Gilotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijcard.2024.131853_bb0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2024.131853_bb0010","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.ijcard.2024.131853_bb0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pcad.2009.11.010","article-title":"Diagnosis and management of cardiac sarcoidosis","volume":"52","author":"Dubrey","year":"2010","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131853_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead019","article-title":"Modern tools in cardiac imaging to assess myocardial inflammation and infection","volume":"3","author":"Hutt","year":"2023","journal-title":"Eur. Heart J. Open"},{"issue":"8","key":"10.1016\/j.ijcard.2024.131853_bb0025","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.ijcard.2024.131853_bb0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1034\/j.1399-0039.2000.560107.x","article-title":"HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis","volume":"56","author":"Naruse","year":"2000","journal-title":"Tissue Antigens"},{"issue":"11","key":"10.1016\/j.ijcard.2024.131853_bb0035","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2024.131853_bb0040","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/EDE.0000000000000471","article-title":"Review article","volume":"27","author":"Ogino","year":"2016","journal-title":"Epidemiology (Cambridge, Mass)"},{"issue":"7\u20138","key":"10.1016\/j.ijcard.2024.131853_bb0045","first-page":"372","article-title":"Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan","volume":"43","author":"Iwai","year":"1993","journal-title":"Pathol. Int."},{"issue":"9","key":"10.1016\/j.ijcard.2024.131853_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.009966","article-title":"Sex differences in patients with suspected cardiac sarcoidosis assessed by cardiovascular magnetic resonance imaging","volume":"14","author":"Kalra","year":"2021","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"4","key":"10.1016\/j.ijcard.2024.131853_bb0055","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","article-title":"Isolated cardiac sarcoidosis: a focused review of an under-recognized entity","volume":"25","author":"Okada","year":"2018","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131853_bb0060","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2024.131853_bb0065","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis | circulation","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcard.2024.131853_bb0070","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacc.2020.06.038","article-title":"Long-term adverse cardiac outcomes in patients with sarcoidosis","volume":"76","author":"Yafasova","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131853_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2023.03.022","article-title":"Sex and race differences in cardiac sarcoidosis presentation, treatment, and outcomes","author":"Duvall","year":"2023","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2024.131853_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2022-322243","article-title":"Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis","author":"Iso","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2024.131853_bb0085","doi-asserted-by":"crossref","first-page":"106864","DOI":"10.1016\/j.rmed.2022.106864","article-title":"Cardiac sarcoidosis outcome differences: a comparison of patients with de novo cardiac versus known extracardiac sarcoidosis at presentation","volume":"198","author":"Rosen","year":"2022","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2024.131853_bb0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.amjcard.2008.08.053","article-title":"Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical \u201ccore\u201d excised for insertion of a left ventricular assist device for severe chronic heart failure","volume":"103","author":"Roberts","year":"2009","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2024.131853_bb0095","doi-asserted-by":"crossref","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.ijcard.2024.131853_bb0100","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/pace.12277","article-title":"Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia","volume":"37","author":"Nery","year":"2014","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"37","key":"10.1016\/j.ijcard.2024.131853_bb0105","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstr\u00f6m","year":"2019","journal-title":"Eur. Heart J."},{"issue":"13","key":"10.1016\/j.ijcard.2024.131853_bb0110","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.121.058120","article-title":"Incidence of sudden cardiac death and life-threatening arrhythmias in clinically manifest cardiac sarcoidosis with and without current indications for an implantable cardioverter defibrillator","volume":"146","author":"Nordenswan","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2024.131853_bb0115","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"7","key":"10.1016\/j.ijcard.2024.131853_bb0120","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm."},{"issue":"11","key":"10.1016\/j.ijcard.2024.131853_bb0125","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2024.131853_bb0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2021.04.022","article-title":"Identification of a novel presumed cardiac sarcoidosis category for patients at high risk of disease","volume":"335","author":"Rosenbaum","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131853_bb0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCEP.113.000932","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear","volume":"7","author":"Philips","year":"2014","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131853_bb0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.hrthm.2020.09.015","article-title":"Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC task force criteria","volume":"18","author":"Gasperetti","year":"2021","journal-title":"Heart Rhythm."},{"issue":"3","key":"10.1016\/j.ijcard.2024.131853_bb0145","article-title":"Routine laboratory biomarkers as prognostic indicators of cardiac sarcoidosis outcomes","volume":"39","author":"Kolluri","year":"2022","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131853_bb0150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jjcc.2020.07.006","article-title":"The ECG in sarcoidosis - a marker of cardiac involvement? Current evidence and clinical implications","volume":"77","author":"Willy","year":"2021","journal-title":"J. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2024.131853_bb0155","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1540-8167.2011.02099.x","article-title":"Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement","volume":"22","author":"Schuller","year":"2011","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"12","key":"10.1016\/j.ijcard.2024.131853_bb0160","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1111\/echo.14886","article-title":"Speckle tracking echocardiography can predict subclinical myocardial involvement in patients with sarcoidosis: a meta-analysis","volume":"37","author":"Barssoum","year":"2020","journal-title":"Echocardiography."},{"issue":"11","key":"10.1016\/j.ijcard.2024.131853_bb0165","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jacc.2004.11.069","article-title":"Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches","volume":"45","author":"Abdel-Aty","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2024.131853_bb0170","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.echo.2015.02.018","article-title":"Myocardial damage detected by two-dimensional speckle-tracking echocardiography in patients with extracardiac sarcoidosis: comparison with magnetic resonance imaging","volume":"28","author":"Orii","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"3","key":"10.1016\/j.ijcard.2024.131853_bb0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jcmg.2022.10.018","article-title":"Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis","volume":"16","author":"Stevenson","year":"2023","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.ijcard.2024.131853_bb0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12350-017-1043-4","volume":"25","author":"Slart","year":"2018","journal-title":"J. Nucl. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2024.131853_bb0185","first-page":"220","article-title":"Positron emission tomography in heart failure: from pathophysiology to clinical application","volume":"10","author":"Tersalvi","year":"2023","journal-title":"J Cardiovasc. Dev. Dis."},{"issue":"8","key":"10.1016\/j.ijcard.2024.131853_bb0190","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2024.131853_bb0195","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1007\/s12350-023-03296-2","article-title":"Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET\/CT","volume":"30","author":"Chan","year":"2023","journal-title":"J. Nucl. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2024.131853_bb0200","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jchf.2014.03.015","article-title":"Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis","volume":"2","author":"Liang","year":"2014","journal-title":"JACC Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131853_bb0205","doi-asserted-by":"crossref","first-page":"1601290","DOI":"10.1183\/13993003.01290-2016","article-title":"Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study 1976\u20132013","volume":"49","author":"Ungprasert","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.ijcard.2024.131853_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033442","article-title":"Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden","volume":"7","author":"Z\u00f6ller","year":"2012","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.ijcard.2024.131853_bb0215","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review","volume":"76","author":"Trivieri","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.131853_bb0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cardfail.2021.06.016","article-title":"Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review","volume":"28","author":"Gilotra","year":"2022","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2024.131853_bb0225","doi-asserted-by":"crossref","DOI":"10.1007\/s12350-022-03171-6","article-title":"Prednisone vs methotrexate in treatment na\u00efve cardiac sarcoidosis","author":"Vis","year":"2023","journal-title":"J. Nucl. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2024.131853_bb0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131853_bb0235","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2016.11.142","article-title":"Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis","volume":"228","author":"Shelke","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"17","key":"10.1016\/j.ijcard.2024.131853_bb0240","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","article-title":"Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis","volume":"44","author":"Lehtonen","year":"2023","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2024.131853_bb0245","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jcmg.2019.12.013","article-title":"Effect of corticosteroid dose and duration on 18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"13","author":"Okada","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"9","key":"10.1016\/j.ijcard.2024.131853_bb0250","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131853_bb0255","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijcard.2016.10.101","article-title":"Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis","volume":"227","author":"Padala","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2024.131853_bb0260","first-page":"1034","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131853_bb0265","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.amjcard.2022.04.051","article-title":"Effect of corticosteroids on left ventricular function in patients with cardiac sarcoidosis","volume":"177","author":"Wand","year":"2022","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2024.131853_bb0270","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.amjcard.2015.12.033","article-title":"Effect of discontinuation of prednisolone therapy on risk of cardiac mortality associated with worsening left ventricular dysfunction in cardiac sarcoidosis","volume":"117","author":"Nagai","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131853_bb0275","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2019.10.003","article-title":"Cardiac sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)","volume":"220","author":"Birnie","year":"2020","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131853_bb0280","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1586\/17476348.2015.1002471","article-title":"Prophylaxis for pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?","volume":"9","author":"Liebling","year":"2015","journal-title":"Expert Rev. Respir. Med."},{"issue":"12","key":"10.1016\/j.ijcard.2024.131853_bb0285","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.cardfail.2021.06.010","article-title":"Management of cardiac sarcoidosis using mycophenolate mofetil as a steroid-sparing agent","volume":"27","author":"Griffin","year":"2021","journal-title":"J. Card. Fail."},{"issue":"12","key":"10.1016\/j.ijcard.2024.131853_bb0290","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ejhf.1319","article-title":"Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres","volume":"20","author":"Fussner","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"25","key":"10.1016\/j.ijcard.2024.131853_bb0295","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2024.131853_bb0300","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.amjcard.2023.07.139","article-title":"Clinical response to tumor necrosis factor-\u03b1 inhibitor therapy in the management of cardiac sarcoidosis","volume":"205","author":"Churchill","year":"2023","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2024.131853_bb0305","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.amjcard.2019.07.067","article-title":"Infliximab for refractory cardiac sarcoidosis","volume":"124","author":"Harper","year":"2019","journal-title":"Am. J. Cardiol."},{"issue":"18","key":"10.1016\/j.ijcard.2024.131853_bb0310","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-term corticosteroid-sparing immunosuppression for cardiac sarcoidosis","volume":"8","author":"Rosenthal","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.ijcard.2024.131853_bb0315","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2020.08.013","article-title":"Clinical and imaging response to tumor necrosis factor alpha inhibitors in treatment of cardiac sarcoidosis: a multicenter experience","volume":"27","author":"Gilotra","year":"2021","journal-title":"J. Card. Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131853_bb0320","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cardfail.2021.07.008","article-title":"Rituximab for the treatment of refractory cardiac sarcoidosis: a single-center experience","volume":"28","author":"Elwazir","year":"2022","journal-title":"J. Card. Fail."},{"issue":"1","key":"10.1016\/j.ijcard.2024.131853_bb0325","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12967-021-03130-8","article-title":"Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra randomized trial (MAGiC-ART)","volume":"19","author":"Kron","year":"2021","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131853_bb0330","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/hrt.2005.080481","article-title":"Cardiac sarcoidosis","volume":"92","author":"Doughan","year":"2006","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.ijcard.2024.131853_bb0335","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/jce.14082","article-title":"Regional abnormalities on cardiac magnetic resonance imaging and arrhythmic events in patients with cardiac sarcoidosis","volume":"30","author":"Okada","year":"2019","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"10","key":"10.1016\/j.ijcard.2024.131853_bb0340","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011253","article-title":"Myocardial involvement in patients with histologically diagnosed cardiac sarcoidosis: a systematic review and meta-analysis of gross pathological images from autopsy or cardiac transplantation cases","volume":"8","author":"Okasha","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.ijcard.2024.131853_bb0345","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1378\/chest.11-3214","article-title":"Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications","volume":"143","author":"Viles-Gonzalez","year":"2013","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.ijcard.2024.131853_bb0350","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jcmg.2022.02.025","article-title":"Incidence and predictors of atrial fibrillation in cardiac sarcoidosis: a multimodality imaging study","volume":"15","author":"Niemel\u00e4","year":"2022","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"3","key":"10.1016\/j.ijcard.2024.131853_bb0355","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jcmg.2020.08.037","article-title":"Multimodality imaging of atrial remodeling and risk of atrial fibrillation in patients with cardiac sarcoidosis","volume":"14","author":"Habibi","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"3","key":"10.1016\/j.ijcard.2024.131853_bb0360","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCEP.113.000734","article-title":"Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis","volume":"7","author":"Naruse","year":"2014","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.131853_bb0365","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCEP.114.002145","article-title":"Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation","volume":"8","author":"Kumar","year":"2015","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.131853_bb0370","doi-asserted-by":"crossref","DOI":"10.1186\/s41824-021-00119-w","article-title":"Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis","volume":"5","author":"Cheung","year":"2021","journal-title":"Eur. J. Hybrid Imaging"},{"issue":"9","key":"10.1016\/j.ijcard.2024.131853_bb0375","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/echo.13637","article-title":"Cardiac sarcoidosis diagnosed by multimodality imaging","volume":"34","author":"Fujikura","year":"2017","journal-title":"Echocardiography"},{"issue":"4","key":"10.1016\/j.ijcard.2024.131853_bb0380","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"12","key":"10.1016\/j.ijcard.2024.131853_bb0385","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCULATIONAHA.118.034687","article-title":"Ventricular arrhythmias in cardiac sarcoidosis","volume":"138","author":"Okada","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2024.131853_bb0390","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ehf2.12201","article-title":"Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis","volume":"5","author":"Smedema","year":"2018","journal-title":"ESC Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2024.131853_bb0395","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jcmg.2022.10.018","article-title":"Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis","volume":"16","author":"Stevenson","year":"2023","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2024.131853_bb0400","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijcard.2020.11.044","article-title":"Risk and predictors of sudden death in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"328","author":"Franke","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131853_bb0405","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222483","article-title":"Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"307","author":"Aitken","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.ijcard.2024.131853_bb0410","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.amjcard.2020.08.007","article-title":"Utility of cardiac magnetic resonance imaging versus cardiac positron emission tomography for risk stratification for ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"134","author":"Gowani","year":"2020","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.131853_bb0415","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","article-title":"Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation","volume":"4","author":"Mehta","year":"2011","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ijcard.2024.131853_bb0420","first-page":"100342","article-title":"Electrophysiology study for risk stratification in patients with cardiac sarcoidosis and abnormal cardiac imaging","volume":"23","author":"Okada","year":"2019","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"10.1016\/j.ijcard.2024.131853_bb0425","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2021.11.061","article-title":"The role of electrophysiology study in risk stratification of cardiac sarcoidosis patients: meta-analyses and systemic review","volume":"349","author":"Adhaduk","year":"2022","journal-title":"Int. J. Cardiol."},{"issue":"13","key":"10.1016\/j.ijcard.2024.131853_bb0430","first-page":"e210","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcard.2024.131853_bb0435","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007488","article-title":"Assessment of the 2017 AHA\/ACC\/HRS guideline recommendations for implantable cardioverter-defibrillator implantation in cardiac sarcoidosis","volume":"12","author":"Kazmirczak","year":"2019","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"40","key":"10.1016\/j.ijcard.2024.131853_bb0440","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ijcard.2024.131853_bb0445","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamacardio.2022.2981","article-title":"Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis","volume":"7","author":"Athwal","year":"2022","journal-title":"JAMA Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131853_bb0450","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.amjcard.2018.09.044","article-title":"Effect of cardiac resynchronization therapy on left ventricular remodeling in patients with cardiac sarcoidosis","volume":"123","author":"Patel","year":"2019","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2024.131853_bb0455","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1111\/jce.15631","article-title":"Cardiac resynchronization therapy response in cardiac sarcoidosis","volume":"33","author":"Shabtaie","year":"2022","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"5","key":"10.1016\/j.ijcard.2024.131853_bb0460","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/europace\/euw223","article-title":"Cardiac resynchronization therapy for patients with cardiac sarcoidosis","volume":"19","author":"Sairaku","year":"2017","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.ijcard.2024.131853_bb0465","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jce.13228","article-title":"Tailored approach for management of ventricular tachycardia in cardiac sarcoidosis","volume":"28","author":"Yalagudri","year":"2017","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"6","key":"10.1016\/j.ijcard.2024.131853_bb0470","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003353","article-title":"Time course and factors correlating with ventricular tachyarrhythmias after introduction of steroid therapy in cardiac sarcoidosis","volume":"9","author":"Segawa","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"8","key":"10.1016\/j.ijcard.2024.131853_bb0475","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004333","article-title":"Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"9","author":"Muser","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"9","key":"10.1016\/j.ijcard.2024.131853_bb0480","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.hrthm.2019.02.025","article-title":"Cardiac sympathectomy for refractory ventricular arrhythmias in cardiac sarcoidosis","volume":"16","author":"Okada","year":"2019","journal-title":"Heart Rhythm."},{"issue":"12","key":"10.1016\/j.ijcard.2024.131853_bb0485","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14109","article-title":"Comparing outcomes for infiltrative and restrictive cardiomyopathies under the new heart transplant allocation system","volume":"34","author":"Griffin","year":"2020","journal-title":"Clin. Transpl."},{"issue":"13","key":"10.1016\/j.ijcard.2024.131853_bb0490","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","volume":"68","author":"Yancy","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.131853_bb0495","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/eurheartj\/ehy730","article-title":"Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the sport cardiology section of the European association of preventive cardiology (EAPC)","volume":"40","author":"Pelliccia","year":"2019","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2024.131853_bb0500","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The international society for heart and lung transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J. Heart Lung Transplant."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131853_bb0505","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 international society for heart and lung transplantation guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J. Heart Lung Transplant."},{"issue":"6","key":"10.1016\/j.ijcard.2024.131853_bb0510","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.transproceed.2013.02.116","article-title":"Heart transplantation for end-stage heart failure due to cardiac sarcoidosis","volume":"45","author":"Perkel","year":"2013","journal-title":"Transplant. Proc."},{"issue":"5","key":"10.1016\/j.ijcard.2024.131853_bb0515","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jjcc.2012.07.013","article-title":"Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation--single-center retrospective analysis","volume":"60","author":"Akashi","year":"2012","journal-title":"J. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2024.131853_bb0520","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/MAT.0000000000001262","article-title":"Natural history of patients diagnosed with cardiac sarcoidosis at left ventricular assist device implantation or cardiac transplantation","volume":"67","author":"Schmidt","year":"2021","journal-title":"ASAIO J."},{"key":"10.1016\/j.ijcard.2024.131853_bb0525","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.122.003850","article-title":"Prevalence of pathogenic variants in dilated cardiomyopathy-associated genes in patients evaluated for cardiac sarcoidosis","author":"Reza","year":"2023","journal-title":"Circ. Genom. Precis. Med."},{"issue":"23","key":"10.1016\/j.ijcard.2024.131853_bb0530","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018866","article-title":"Left ventricular dysfunction in arrhythmogenic right ventricular cardiomyopathy (ARVC): can we separate ARVC from other arrhythmogenic cardiomyopathies?","volume":"9","author":"Altmayer","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.ijcard.2024.131853_bb0535","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019415","article-title":"Manifestations and outcome of cardiac sarcoidosis and idiopathic giant cell myocarditis by 25-year nationwide cohorts","volume":"10","author":"Nordenswan","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.ijcard.2024.131853_bb0540","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/ehjci\/jeac265","article-title":"Cardiac magnetic resonance in giant cell myocarditis: a matched comparison with cardiac sarcoidosis","volume":"24","author":"P\u00f6yh\u00f6nen","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2024.131853_bb0545","doi-asserted-by":"crossref","first-page":"131143","DOI":"10.1016\/j.ijcard.2023.131143","article-title":"Phenotyping of giant cell myocarditis versus cardiac sarcoidosis using cardiovascular magnetic resonance","volume":"387","author":"Bobbio","year":"2023","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324002602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324002602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:04:09Z","timestamp":1759093449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324002602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":109,"alternative-id":["S0167527324002602"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.131853","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and management strategies in cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.131853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"131853"}}